The results revealed that the overall survival of LC patients with high expression of GAPDG, AKT1, TP53, IL6 and MPKA3 was significantly lower than that in patients with their low expression (p < 0.01) (Figure 11). The gene discussed is TP53; the disease is laryngotracheoesophageal cleft.